Brand profile · Biotechnology Research

Entobel

Entobel is a Biotechnology Research brand in Singapore. Ownership is privately held; it publishes at entobel.com. The record carries two addresses across two office countries. The record counts 59 people. Its latest round on record is Series B, US$30.0M. It is listed alongside three similar brands, mostly in Food and Beverage Manufacturing.

Profile live Privately Held Founded 2013 2 office countries US$ 30.0M Series B

Key facts

Counted staff
59
self-reported 51–200 band
Founded
2013
13 years
Legal entities
None matched
Office countries
2
2 addresses
Funding rounds
5
Series B · Jun 2022 · US$ 30.0M
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Description

Entobel is converting low value organic substrate into high quality products thanks to insects.

Our main current products are sustainable animal feed (proteins and oils) and organic fertilizer.

Since 2013, Entobel is running a commercial scale production site in Vietnam and exporting products worldwide.

Entobel complies with highest standards in the industry (ISO 22000), only use tracable feedstocks and is FDA approved.

Entobel is looking for strong partners to join for its expansion plans. Don't hesitate to contact us for more information.

Locations

2
Countries with an office address2 addresses on record

Country footprint

Offices in 2 countriesCountry footprint: 2 countries, primary SG. Codes: SG, VN.2 countriesprimary SGSGVN
Show as table · Offices in 2 countries
Offices in 2 countries
Countries2
Primary countrySG

All codes: SG VN

Addresses

  • SGSingapore, Singapore 051531Primary
  • VNHo Chi Minh City, Ho Chi Minh City 70000

Grid intelligence Members

Funding

Last round · 9 June 2022US$ 30.0MSeries B · investor: Mekong Capital
Rounds5
Round typeSeries B · venture round
Amount (USD)30,000,000
Stage rank4
Investors named1
Since last round3 yr 7 mo

Funding

5 funding roundsFunding timeline. Latest round 9 Jun 2022: Series B, US$ 30.0M.20132026Series BUS$ 30.0M5 rounds
Show as table · 5 funding rounds
5 funding rounds
Rounds5
Axis2013 to 2026
Series B · 9 Jun 2022US$ 30.0M

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

How many people work at Entobel?

The record holds 59 counted staff profiles at January 2026, inside the self-reported 51–200 band.

Where does Entobel have offices?

Two addresses on record across 2 countries. Primary: Singapore 051531.

Has Entobel raised funding?

Five rounds. Latest 9 June 2022: Series B, US$30,000,000, investor Mekong Capital.

Which companies are listed alongside Entobel?

19 profiles list Entobel as a peer — 93rd percentile in Biotechnology Research. It lists ten peers of its own. Skretting Vietnam and Sentara Group list it back.

What is Entobel's website?